1. Introduction
In recent years, there has been a notable rise in the incidence of respiratory infections among canines, with certain cases exhibiting contagious properties that significantly compromise the health and quality of life of affected dogs. This trend also poses substantial challenges to the daily management and breeding operations within kennels. ExPEC, a prevalent Gram-negative bacterium in animals, has been identified as a causative agent of various infections, including respiratory infections, urinary tract infections, and bacteremia, among others [
1]. Several studies have isolated and identified ExPECs in the lungs of animals. For instance, Edward B. et al. isolated pathogenic ExPEC from a 7-month-old dog presenting with acute necrotizing pneumonia [
2]. A U.S. study conducted between 2013 and 2021 confirmed ExPEC in all 21 cases of canine hemorrhagic pneumonia through pathogen cultivation and identification [
3]. Additionally, Yu Y. et al. also identified 85 strains of
Escherichia coli from 115 mink lung samples affected by hemorrhagic pneumonia [
4]. All animals in these studies exhibited symptoms such as lethargy, anorexia, and respiratory distress. Necropsies revealed varying degrees of lung hemorrhages, with hemorrhagic pneumonia identified as the primary cause of death in all cases. These findings bear a striking resemblance to the symptoms observed in four recent sporadic cases of acute pneumonia in puppies at a kennel in Guangdong Province, China.
The classical clinical diagnosis and identification of ExPEC in animals primarily rely on the investigation of medical history, clinical symptomatology, biochemical identification, and antimicrobial susceptibility testing. This approach allows treatment with appropriate drugs, typically obviating the need for further differentiation [
5,
6]. However, with the gradual increase in the number of ExPEC cases, traditional methods are insufficient to fully elucidate the epidemiology, pathogenesis, and phylogenetic characteristics of ExPEC infections. Moreover, despite the availability of analogous cases for reference, the determination of whether the acute pneumonia observed in puppies at a kennel in Guangdong Province is indeed attributable to ExPEC, and whether it constitutes a broader threat to the canine population remains an urgent issue requiring further investigation. Therefore, this study identified pathogens in puppies with acute pneumonia using microbiological tests and antimicrobial susceptibility testing, followed by bacterial virulence gene detection, MLST, and WGS. These methodologies facilitated the identification of previously unrecognized pathogens of this disease, thereby elucidating their pathogenic mechanisms and informing strategies for future prevention and therapeutic interventions.
2. Materials and Methods
2.1. Main Reagents and Main Instruments
TSA, TSB, blood agar plates, MacConkey agar, eosin methylene blue agar, Gram staining solutions, Escherichia coli biochemical identification kits, and McFarland standard turbidity tubes were all procured from Guangdong HuanKai Microbial Sci. & Tech. Co., Ltd., Guangzhou, China. Bacterial genomic DNA extraction kits were obtained from Tiangen Bio-chemical Technology Co., Ltd., Beijing, China Green Taq Mix was sourced from Nanjing Novozan Biotech Co., Ltd., Nanjing, China. Gel Red was acquired from Shanghai Biyuntian Biotechnology Co., Ltd., Shanghai, China. The DL-2000 DNA Marker was procured from TaKaRa, Osaka, Japan. Antibiotic susceptibility test disks were purchased from Hangzhou Microbial Reagent Co., Ltd., Hangzhou, China. The ultra-clean workbench was procured from Suzhou Purification Equipment Co., Ltd., Suzhou, China. The high-pressure autoclave was sourced from Shanghai Boxun Medical Biological Instrument Co., Ltd., Shanghai, China, while the electric thermostatic incubator was obtained from Shanghai Yiheng Scientific Instrument Co., Ltd., Shanghai, China. The desktop thermostatic shaker was acquired from Shanghai Hecheng Instrument Manufacturing Co., Ltd., Shanghai, China, and the research-grade upright microscope was supplied by Olympus Corporation, Tokyo, Japan. Additionally, the high-speed centrifuge was provided by Hunan Xiangyi Laboratory Instrument Development Co., Ltd., Hunan, China. The PCR thermal cycler was purchased from Biometra, Germany. The universal electrophoresis apparatus was obtained from Junyi Dongfang Electrophoresis Equipment Co., Ltd., Beijing, China, and the multifunctional chemiluminescence imaging system was acquired from UVP, CA, USA.
2.2. Animals
The experimental samples were aseptically collected from four puppies (one male and three females) aged between 3 and 5 months and weighing an average of 6.7 ± 1.4 kg, all of which were diagnosed with acute pneumonia and housed in a kennel in Guangdong Province.
2.3. Experimental Methods
2.3.1. Case History Investigation
In a kennel in Guangdong Province, four sporadic instances of acute pneumonia in puppies were documented between December 2023 and May 2024. The clinical manifestations predominantly encompassed lethargy, anorexia, tachypnea with pronounced abdominal effort, and hypersalivation. Following the identification of the cases, the broad-spectrum antibacterial agent ampicillin sodium (approval number: 070011304) was promptly administered intravenously as an emergency intervention at a dosage of 30 mg/kg, administered twice daily for two consecutive days. Despite these therapeutic interventions, the conditions of the dogs continued to deteriorate rapidly. Some cases exhibited the exudation of a reddish foamy substance from the nasal and oral cavities. All cases showed a rapid onset, severe clinical presentation, and poor prognosis, ultimately resulting in mortality within 72 h of initiating treatment. Furthermore, the investigation revealed that all the puppies that exhibited illness had received vaccinations for canine distemper, adenovirus, parainfluenza, parvovirus, coronavirus, and leptospirosis serotypes, attaining standard immunization levels. This finding excluded the likelihood of prevalent common severe infectious diseases in the canine population.
2.3.2. Isolation, Cultivation, and Identification of Pathogens
In an aseptic surgical procedure, puppies afflicted with severe pneumonia were anesthetized. Subsequently, three BAL fluid samples, each with a volume of 2–3 mL, were collected from each canine subject. These samples were then injected into Amies transport medium containing activated charcoal and transported to Zoetis Inc. at ambient temperature. Upon arrival, the samples underwent bacterial isolation, culture, purification, and biochemical identification. Universal primers for bacterial 16S rRNA were designed following the methodology described by I Dewa Made Sukrama et al. [
7] for PCR amplification and bidirectional sequencing of the 16S rRNA fragments. The primer sequences are detailed in
Appendix A,
Table A1. Following the extraction of DNA from four purified bacterial strains, it was extracted using a bacterial genome extraction kit. PCR was performed in a 25 μL reaction mixture containing 12.5 μL of Premix Ex Taq, 2 μL of DNA, 8.5 μL of ddH
2O, and 1 μL each of forward and reverse primers. The amplification protocol included initial denaturation at 95 °C for 3 min; 35 cycles of 95 °C for 15 s, 57.5 °C for 15 s, and 72 °C for 1 min; and a final extension at 72 °C for 5 min. PCR products were analyzed on a 1% agarose gel at 150 V and 500 mA for 30 min. Upon observing a single band without non-specific amplification, 10 μL of the unpurified PCR products were submitted to Sangon Biotech Co., Ltd., (Shanghai, China) for sequencing.
2.3.3. Pathological Autopsy Observations
After euthanizing the puppies, the thoracic cavity was opened to examine lung morphology and pathology. Typical lung tissue lesions were fixed in 10% neutral buffered formalin, processed for routine paraffin embedding, sectioned, and stained with hematoxylin and eosin (H&E) for a microscopic histological analysis.
2.3.4. Bacterial Whole-Genome Sequencing
The DNA of the four purified strains was extracted and dispatched to Sangon Biotech Co., Ltd., (Shanghai, China) for high-throughput sequencing utilizing the Illumina platform. The raw data (RawReads) underwent rigorous quality assessment and quality control (QC) procedures, which included the removal of adapter sequences, low-quality sequences, and contaminants, resulting in clean data (clean reads). The genome assembly was performed using software tools such as SPAdes (v. 3.5.0) and Pilon (v. 1.23) to generate contigs and scaffolds. Gene prediction and annotation in the assembled genome were conducted using software like Prokka (v. 1.10) to identify coding sequences (CDSs), RNA genes, and other genomic features. Drug resistance genes and virulence factors were identified utilizing databases including the Comprehensive Antibiotic Resistance Database (CARD) and the Virulence Factors Database (VFDB). The MLST analysis was conducted using the PubMLST database to ascertain the sequence type of the strain. Subsequently, SerotypeFinder (v. 2.0) software was employed to conduct serotyping by analyzing sequences of specific O antigen genes (wzx, wzy, wzm, and wzt) and H antigen genes (fliC, flkA, fllA, flmA, and flnA).
2.3.5. Bacterial Antimicrobial Phenotype and Resistance Genes
Typical colonies from the purified bacterial strains were selected and suspended in saline to achieve a turbidity equivalent to a 0.5 McFarland standard turbidity tube (corresponding to a bacterial concentration of 1 × 10
8 CFU/m L). The bacterial suspensions were subsequently adjusted to a concentration of 1 × 10
8 CFU/m L. A volume of 100 μL of the adjusted bacterial suspension was evenly spread onto TSA plates (using a sterile glass rod. Different antibiotic disks were then placed on the agar using sterile tweezers, ensuring a distance of 1.5 cm to 2 cm between each disk. Following a 15 min settling period, the plates were incubated in an inverted position overnight at 37 °C. Subsequent observations involved measuring the diameters of the inhibition zones using a caliper. According to the Clinical and Laboratory Standards Institute (CLSI) document VET01S (CLSI, 2024) [
8], the test standards delineated in
Table 1 were employed to document the drug resistance phenotype of the strain. Additionally, the resistance genes of the bacteria were analyzed based on the WGS results.
2.3.6. Virulence Gene Detection
Utilizing purified strain DNA as a template, the detection of virulence genes in four isolated pathogens was performed using PCR. In accordance with references [
4,
9,
10], primers were designed for 18 types of virulence genes spanning the following six categories: genes related to invasiveness (e.g.,
hlyF), iron uptake (e.g.,
fyuA,
iucD,
irp2,
iroN), adhesion (e.g.,
fimC,
papC,
fimH,
tsh,
K99), toxin production (e.g.,
CNF-I,
vat,
STa,
STb), biofilm formation (e.g.,
ompA), serum resistance (e.g.,
cva/cvi,
iss), and the LEE pathogenicity island (e.g.,
eae). The sequences of these primers are provided in
Appendix A,
Table A1. The amplification process is performed in a 25 μL reaction system with an initial denaturation at 95 °C for 3 min, followed by 35 cycles at 95 °C for 30 s, 55.3 °C for 30 s, and 72 °C for 1 min, ending with a final extension at 72 °C for 5 min. PCR products are analyzed using 1% agarose gel electrophoresis.
2.3.7. MLST
Utilizing the PubMLST database (URL
http://pubmlst.org, accessed on 6 June 2024) in conjunction with the relevant literature [
11], primer sequences were designed for seven housekeeping genes of
Escherichia coli, namely
adK,
fumC,
gyrB,
icd,
mdh,
purA, and
recA. The specific primer sequences are provided in
Appendix A,
Table A1. Purified strain DNA served as the template for the PCR amplification of these seven housekeeping genes. The resulting PCR products were subsequently submitted to Sangon Biotech Co. Ltd. (Shanghai, China) for bidirectional sequencing. The sequencing results were submitted electronically to the PubMLST Achtman database for comparative analysis. The allele numbers for each of the seven housekeeping gene loci were retrieved. Upon comparing the seven genes of each strain, an allelic profile comprising seven numeric alleles was established. Entering this allelic profile into the MLST database yielded a sequence type (ST), thus determining the multilocus sequence type of the strain.
2.3.8. Detection of Escherichia coli and CNF-I Virulence Gene in Drinking Water Sources
A total of 19 tap water samples from a kennel were collected. A total of 1 mL of each sample was dispensed onto TSA solid culture medium using the pour plate method and incubated at 37 °C for 48 h. Upon the development of visible colonies, colonies for further culture in TSB medium overnight were selected. Subsequently, DNA was extracted from the cultured broth. PCR was conducted using universal primers for Escherichia coli (primer sequences are provided in the appendix) and primers specific to the CNF-I virulence gene. Following PCR amplification, an appropriate volume of the PCR product was subjected to 1% agarose gel electrophoresis for analysis.
4. Discussion
In recent years, the emergence of multidrug-resistant Gram-negative bacteria has elicited significant global concerns within the realms of both human and veterinary medicine. The emergence of these resistant strains presents a significant threat to public health and undermines the efficacy of clinical treatments. In clinical microbiology laboratories, the production of ESBLs in Gram-negative bacteria is characterized by reduced susceptibility to one or more of the following antibiotics: ceftazidime, cefpodoxime, ceftriaxone, cefotaxime, or aztreonam. Furthermore, the antimicrobial efficacy of these antibiotics against ESBL-producing bacteria is augmented in the presence of β-lactamase inhibitors such as clavulanic acid or tazobactam [
12]. ESBLs are β-lactamases that can hydrolyze penicillins and cephalosporins, predominantly encompassing the
TEM,
CTX-M,
SHV, and
OXA families [
13,
14]. When
Escherichia coli, a member of the
Enterobacteriaceae family, acquires ESBL genes and produces these enzymes, it develops resistance to this class of β-lactam antibiotics. This study identified four
Escherichia coli isolates using 16S rRNA PCR and performed susceptibility testing with nine classes of antimicrobial drugs. The findings indicated a consistent resistance to cephalosporins, tetracyclines, and penicillins, whereas sensitivity was noted towards aminoglycosides, β-lactamase inhibitors, carbapenems, chloramphenicol, and sulfonamides. Furthermore, high-quality sequencing data revealed that all isolates harbored the
TEM,
CTX-M-55,
mec,
tet,
AAC-IId,
cmlA,
dfrA, and
sul genes, with
TEM and
CTX-M-55 being particularly prevalent in companion animal
Escherichia coli that produces ESBLs [
15,
16,
17]. The
TEM-206 variant identified in this study represents a unique beta-lactamase, typically categorized as a specific third-generation ESBL due to its capability to hydrolyze a broad range of beta-lactam antibiotics, including those classified as third-generation [
18]. The presence of this enzyme in bacterial strains imparts resistance to antibiotics commonly employed in the treatment of severe infections. In summary, the observed ESBL production and multidrug resistance of the isolates align with findings from previous studies [
19].
The pathogenicity of
Escherichia coli is predominantly dictated by specific virulence genes, such as invasins, adhesins, toxins, and capsules. These genes are frequently organized into extensive genetic regions located on chromosomes, plasmids, or bacteriophages, and they possess the capability for horizontal transfer between strains [
20]. One notable virulence factor is cytotoxic necrotizing factor I (
CNF-I), a protein toxin synthesized by pathogenic strains.
CNF-I exerts its effects by permanently activating the regulatory GTPases Rho, Rac, and Cdc42 in eukaryotic cells through the deamidation of glutamine residues. This activation promotes gene transcription and cell proliferation, thereby enhancing bacterial survival [
21]. A 2021 study investigating hemorrhagic pneumonia in a range of animal species, including canines, felines, tigers, and equines, analyzed the virulence genes in
Escherichia coli isolates. The findings revealed that all isolates tested positive for
CNF-I [
22]. Furthermore, numerous studies have demonstrated that
CNF-I is crucial in the pathogenesis of
Escherichia coli-induced hemorrhagic pneumonia [
3,
4,
23]. Given that the presence of a single virulence gene is insufficient to convert an
Escherichia coli strain into a pathogenic form and instead requires the interaction of multiple virulence genes [
14], this study aimed to detect 18 specific virulence genes in the isolates. The results revealed that the bacteria harbored
CNF-I,
fyuA,
fimC,
papC,
ompA,
fimH,
irp2, and
iroN, while other virulence genes were absent. Notably, the genes
STa,
STb, and
eae, which tested negative in amplification, are associated with intestinal pathogenic
Escherichia coli (IPEC) and are significant markers for identifying IPEC [
20,
24]. Consequently, although the identification of ExPEC based solely on virulence genes remains impractical [
24], this experiment effectively excludes the isolated strains as IPEC, thereby confirming their classification as ExPEC.
Martin C. initially introduced the MLST technique in 1998. In contrast to conventional molecular typing methods for bacteria, such as random primer PCR and pulsed-field gel electrophoresis, MLST examines the nucleotide sequences within housekeeping genes to identify alleles, thereby facilitating the analysis of strain variations. This technique applies to a broad spectrum of bacterial species, and the results it yields demonstrate high reproducibility across different laboratories [
25]. Furthermore, studies have indicated that MLST possesses superior typing capabilities for ESBL-producing
Escherichia coli compared to pulsed-field gel electrophoresis [
26]. As a sequencing technology, WGS offers a more comprehensive view of genomic information, with various databases potentially encompassing different strains and gene sequences [
27]. In this study, we employed MLST in conjunction with WGS to analyze four isolated strains. Our results indicated that all strains belonged to ST131 and ST43, as identified by the Achtman and Pasteur databases, respectively, with no novel ST types detected. ST131, a widespread clonal type of
Escherichia coli, is implicated in a range of human and animal infections, including asymptomatic bacteriuria, upper gastrointestinal infections, septicemia, meningitis, and pneumonia [
28,
29]. It has consistently been classified as ExPEC in numerous studies [
30,
31,
32]. Other MLST investigations have demonstrated that the predominant STs in clinically isolated
Escherichia coli from dogs are ST372 and ST73 [
30,
33,
34], whereas the primary STs associated with respiratory infections are ST12 and ST681 [
33]. Additionally, the WGS analysis in this experiment revealed that the serotypes of these bacteria were all O25:H4. To date, there have been limited reports on O25:H4/ST131 isolates derived from animal lung infection. Even though the ExPEC responsible for acute pneumonia in four puppies in a kennel in Guangdong Province were all identified as O25:H4/ST131 isolates, there is currently no clinical evidence to suggest significant transmissibility based on data surveys conducted over the past six months. This infection is presently considered incidental, and further research is required to ascertain any additional impacts on the canine population.
ExPEC is a multidrug-resistant bacterium, with 84 cases of acute pneumonia in puppies attributed to it documented in the international literature [
2,
3,
22,
23,
35,
36]; however, no domestic cases have been reported to date. In this study, we employed BAL for the first time to collect pathogenic samples from puppies diagnosed with acute pneumonia. In comparison to traditional methods, such as swabbing lung tissue or performing direct lung tissue excision, BAL offers a minimally invasive alternative that obviates the need for thoracotomy. This technique not only enhances diagnostic safety and efficacy but also significantly promotes animal welfare and facilitates postoperative recovery. Furthermore, these ExPEC studies consistently detected the
CNF-I virulence gene, aligning with our findings. This underscores the critical role of
CNF-I in the early diagnosis and intervention of such diseases.
Numerous theories persist regarding the sources and transmission pathways of ST131 ExPEC, encompassing the consumption of animals (particularly poultry), domestic and medical wastewater, interpersonal transmission among veterinary healthcare workers, familial transmission, and occupational contact with animals [
37,
38,
39]. Although this study did not succeed in pinpointing the exact source of infection responsible for sporadic cases in kennels, it was pioneering in the detection of the
CNF-I gene in drinking water samples. This finding effectively rules out the transmission of ST131 ExPEC through the drinking water source in kennels. However, the study’s scope was limited, as it only examined four cases of acute pneumonia in puppies over six months. Consequently, this is insufficient to definitively determine whether ST131 or ST43 ExPEC is the sole pathogen responsible for causing acute pneumonia in all puppies in the future. Additionally,
Escherichia coli is a normal colonizing bacterium in the intestine [
40]. This raises the question of whether there are analogous colonizing microbial communities in the dog’s lungs. What is the relationship between these pulmonary communities and
Escherichia coli? The mechanisms underlying the alterations in the lung’s colonizing microbial communities that lead to infection remain unclear, warranting further investigation.
Currently, the antimicrobial agents frequently employed in veterinary clinical practice for the treatment of Gram-negative bacterial infections encompass cephalosporins, aminoglycosides, quinolones, and β-lactamase inhibitors [
41]. Before initiating treatment, it is imperative to thoroughly review the dog’s history of antibiotic usage to circumvent the administration of drugs to which resistance may have developed. This study meticulously documented the medication histories of the affected dogs, and informed by the outcomes of drug sensitivity assays, proposed the following treatment recommendations: for canines presenting with mild acute pneumonia, initial therapeutic considerations may include the administration of theophylline or anticholinergic agents to achieve bronchodilation. Concurrently, dexamethasone and furosemide may be employed to mitigate the secretion of pulmonary inflammatory exudate and pleural effusion. Additionally, the utilization of a hyperbaric oxygen chamber for oxygen therapy can be instrumental in maintaining adequate blood oxygen saturation levels, while timely electrolyte replenishment should also be ensured. Antimicrobial therapy may involve the administration of penicillins in conjunction with β-lactamase inhibitors. In severe cases or instances where initial treatment proves ineffective—characterized by blood oxygen saturation levels below 90% and respiratory rates exceeding 30 breaths per minute [
42]—it is advisable to integrate considerations of animal welfare and the 3R principle [
43]. This includes the timely euthanasia of affected animals, vigilant monitoring of co-housed dogs, and the implementation of appropriate isolation, disinfection, and other preventive measures. Furthermore, to mitigate the progression of drug resistance, it is imperative to minimize the extensive use of broad-spectrum antibiotics. Moreover, reinforcing feeding management practices and augmenting the innate resistance of the canine population are crucial strategies for the prevention and control of this disease.